Ticker
EYPTCompany Name
EYEPOINT PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 301.15M | $ 2.68M | 0.89% |
3/31/2025 | $ 362.56M | $ 2.13M | 0.59% |
12/31/2024 | $ 418.46M | $ 2.31M | 0.55% |
9/30/2024 | $ 300.92M | $ 2.81M | 0.93% |
6/30/2024 | $ 324.25M | $ 3.67M | 1.13% |
3/31/2024 | $ 329.25M | $ 4.26M | 1.29% |
12/31/2023 | $ 355.18M | $ 3.91M | 1.1% |
9/30/2023 | $ 160.04M | $ 4.58M | 2.86% |
6/30/2023 | $ 175.66M | $ 4.26M | 2.43% |
3/31/2023 | $ 154.59M | $ 4.07M | 2.63% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for EYEPOINT PHARMACEUTICALS INC is calculated as follows: Inventory [ $ 3.64M ] / Assets [ $ 76.79M ]
(=) Inv. to Assets [ 4.74% ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.11% |